Medison buys EchoCath ColorMark devices

Article

EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark

EchoCath of Princeton, NJ, has shipped 50 of its ColorMark needle-biopsy guidance systems to Korean ultrasound vendor Medison. EchoCath said the shipment is the first international delivery of ColorMark, and the company expects to send more ColorMark units to Medison in the next year.

ColorMark consists of a driver box that sends minute vibrations through a disposable clip into a biopsy needle, causing the needle to show up as a stripe of color on color Doppler scans (SCAN 5/19/93). EchoCath believes the system can improve visualization during biopsy procedures, such as breast biopsy exams.

In other EchoCath news, the company this month reported revenues for its second quarter (end-February) of $150,000, compared with no revenues in the same period a year ago, before the company had started actively marketing products. EchoCath's net loss for the quarter was $663,000, compared with a net loss of $1.2 million in the second quarter of 1996.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.